N. Fischer

638 total citations
24 papers, 450 citations indexed

About

N. Fischer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, N. Fischer has authored 24 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in N. Fischer's work include Cancer survivorship and care (5 papers), Kidney Stones and Urolithiasis Treatments (4 papers) and Palliative Care and End-of-Life Issues (3 papers). N. Fischer is often cited by papers focused on Cancer survivorship and care (5 papers), Kidney Stones and Urolithiasis Treatments (4 papers) and Palliative Care and End-of-Life Issues (3 papers). N. Fischer collaborates with scholars based in Germany, Switzerland and Austria. N. Fischer's co-authors include H. Rübben, F.-J. Deutz, Eckhard Frick, Irmgard Bumeder, Guido Giani, Wolfgang Lutzeyer, R. Busch, Stephan Scholl, Gian Domenico Borasio and T. Schröder and has published in prestigious journals such as Blood, Journal of Cleaner Production and The Journal of Urology.

In The Last Decade

N. Fischer

24 papers receiving 430 citations

Peers

Countries citing papers authored by N. Fischer

Since Specialization

Citations

This map shows the geographic impact of N. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Fischer more than expected).

Fields of papers citing papers by N. Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Fischer. The network helps show where N. Fischer may publish in the future.

Co-authorship network of co-authors of N. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of N. Fischer. A scholar is included among the top collaborators of N. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Fischer. N. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Unveiling the Digital Evolution of Molecular Tumor Boards 2024 ·Targeted Oncology ·(unknown), Armando D’Angelo, (unknown), (unknown), Rainer Claus, N. Fischer, Frank Krämer, (unknown)	1
2	Severe motor aphasia after reinfusion of cryopreserved autologous stem cells after myeloablative conditioning 2016 ·Transfusion ·Andreas Hausmann, N. Fischer, (unknown), (unknown), (unknown), (unknown), Clemens‐Martin Wendtner, Marcus Hentrich	3
3	Overall Survival In Early Stage Chronic Lymphocytic Leukemia Patients With Treatment Indication Due To Disease Progression: Follow-Up Data Of The CLL1 Trial Of The German CLL Study Group (GCLLSG) 2013 ·Blood ·Manuela A. Bergmann, Raymonde Busch, Barbara Eichhorst, (unknown), N. Fischer, Michael J. Eckart, Ursula Vehling‐Kaiser, Ulrich Jäger, Georg Hopfinger, Clemens‐Martin Wendtner, Kirsten Fischer, Bertold Emmerich, Hartmut Döhner, Michael Hallek, Stephan Stilgenbauer	5
4	Cleaning waste minimization for multiproduct plants: transferring macro batch to micro conti manufacturing 2011 ·Journal of Cleaner Production ·(unknown), (unknown), N. Fischer, Stephan Scholl	17
5	From Macro Batch to Micro‐conti Manufacturing: A New Eco‐Friendly Production Process for Writing Ink Employing Micro‐process Engineering 2009 ·Chemical Engineering & Technology ·(unknown), N. Fischer, Stephan Scholl	13
6	Anaphylaktische Reaktion auf Humaninsulin: Erfolgreiche Hyposensibilisierung 2008 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown), N. Fischer, P Müller, H. G. Velcovsky, G Lischka, M. Eggstein	1
7	Tumor patients in psychodynamic psychotherapy including daydreaming: Can imagery enhance primary process and positive emotions? 2008 ·Psychotherapy Research ·Eckhard Frick, (unknown), (unknown), N. Fischer, Irmgard Bumeder, Dan Pokorný	7
8	Patients? health beliefs and coping prior to autologous peripheral stem cell transplantation 2006 ·European Journal of Cancer Care ·Eckhard Frick, Martin Fegg, (unknown), N. Fischer, Irmgard Bumeder	21
9	Social support and quality of life of patients prior to stem cell or bone marrow transplantation 2006 ·British Journal of Health Psychology ·Eckhard Frick, (unknown), Irmgard Bumeder, Frank Schulz‐Kindermann, (unknown), N. Fischer, Monika Hasenbring	17
10	When is the best time for psychotherapeutic intervention following autologous peripheral blood stem cell transplantation? 2006 ·Eckhard Frick, (unknown), N. Fischer, R. Busch, B. Emmerich, Irmgard Bumeder	3
11	Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? 2005 ·Psycho-Oncology ·Eckhard Frick, (unknown), N. Fischer, R. Busch, Irmgard Bumeder	52
12	Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation 2003 ·Psycho-Oncology ·Eckhard Frick, Gian Domenico Borasio, (unknown), N. Fischer, Irmgard Bumeder	45
13	In situ Extracorporeal Shockwave Lithotripsy of Distal Ureteral Stones: Parameters for Therapeutic Success 1994 ·Urologia Internationalis ·P. Mattelaer, T. Schröder, N. Fischer, G. Jakse	32
14	Interleukin 4 inhibits the interleukin 2-induced production of its functional antagonist, interferon gamma 1989 ·Immunology Letters ·F.M. Wagner, N. Fischer, C. Lersch, (unknown), Henryk Dancygier	19
15	Adverse reactions in long‐term interferon treatment 1988 ·Seminars in Surgical Oncology ·(unknown), N. Fischer, (unknown), H. Rübben	2
16	Natural History and Treatment of Low and High Risk Superficial Bladder Tumors 1988 ·The Journal of Urology ·H. Rübben, Wolfgang Lutzeyer, N. Fischer, F.-J. Deutz, (unknown), Guido Giani	152
17	Cavitation Effects: Possible Cause of Tissue Injury During Extracorporeal Shock Wave Lithotripsy 1988 ·Journal of Endourology ·N. Fischer, (unknown), (unknown), (unknown), F.-J. Deutz, H. Rübben, (unknown)	28
18	[Painless extra-corporal shock wave lithotripsy using the HM3 Dornier lithotripter]. 1987 ·PubMed ·N. Fischer, H. Rübben, (unknown), Bernd Forssmann, (unknown), G. Giani	9
19	[Anesthesiologic aspects of extracorporeal shockwave lithotripsy (ESWL)]. 1986 ·PubMed ·(unknown), H. Rübben, (unknown), N. Fischer	1
20	Further Characterization of the Neutrophil-Derived Eosinophil Chemotactic Factor and Comparison to Eosinophil Chemotactic Activity from Mast Cells 1981 ·International Archives of Allergy and Immunology ·Beate M. Czarnetzki, (unknown), N. Fischer	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact